Neurological paraneoplastic syndromes: A review of diagnosis and prospects for therapy

Journal of Clinical Neuroscience

Volumn 3, Issue 1, 1996, Pages 8-15

  Posner, Jerome B ^a   Dalmau, Josep ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Paraneoplastic syndrome

Indexed keywords

EID: 0002685232     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0967-5868(96)90076-4     Document Type: Review

References (34)

1. Posner JB. Neurologic complications of cancer. Philadelphia: F.A.Davis; 1995.
2. Brain WR, Norris FH. The remote effects of cancer on the nervous system. New York: Grune and Stratton; 1965.
3. Elrington GM, Murray NM, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991; 54: 764-7.
4. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988; 111: 577-96.
5. Farrelly C, Daneman A, Chan HSL, Martin DJ. Occult neuroblastoma presenting with opsomyoclonus: Utility of computed tomography. AJR 1995; 142: 807-10.
6. Norris FH, Denys EH, Sang K, Mukai E. Population study of amyotrophic lateral sclerosis. Ann Neurol 1989; 26: 139-40.
7. Posner JB, Furneaux HM. Paraneoplastic syndromes. In: Waksman BH, (ed). Immunologic mechanisms in neurologic and psychiatric disease. New York: Raven Press Ltd. 1990: 187-219.
8. Stefansson K, Morton LS, Dieperink ME, Molnar GK, Schlaepfer WW, Helgason CM. Circulating autoantibodies to the 200,000-Dalton protein of neurofilaments in the serum of healthy individuals. Science 1985; 228: 1117-9.
9. Plioplys AV, Thibault J, Bouchard JP, Cockburn C, Hawkes R. Anti-CNS antibodies in neurological and psychiatric disorders. J Neurol Neurosurg Psychiatry 1987; 50: 1514-21.
10. Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody positive patients. Neurology 1992; 42: 1931-7.
11. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71: 59-72.
12. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri) : The case for a nomenclature based on antibody and antigen specificity. Neurology 1994; 44: 2241-6.
13. Rosenfeld MR, Posner JB. Paraneoplastic motor neuron disease In: Rowland LP (Ed). Advances in neurology, Volume 56: Amyotrophic lateral sclerosis and other motor neuron diseases. New York: Raven Press, 1991; 445-59.
14. Graus F, Bonaventura I, Uchuya M, Valls-Sole J, Rene R, Leger JM, Tolosa E, Delattre J. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology 1994; 44: 2258-61.
15. Furneaux HM, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990; 40: 1085-91.
16. Oppenheim H. Uber Hirnsymptome bei Carcinomatose ohne nachweisbare. Veranderungen im Gehirn. Charite-Ann (Berlin) 1888; 13: 335-44.
17. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948; 11: 73-87.
18. Astrom KE, Mancall EL, Richardson EP. Progressive multifocal leukoencephalopathy. A hitherto unrecognised complication of chronic leukemia and Hodgkin's disease. Brain 1958; 81: 93-111.
19. Paone JF, Jeyasingham K Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Engl J Med 1980; 302: 156
20. Kearsley JH, Johnson P, Halmagyi M. Paraneoplastic cerebellar disease. Remission with excision of the primary tumor. Arch Neurol 1985; 42: 1208-10.
21. Batson OA, Fantle DM, Stewart JA. Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone. Cancer 1992; 69: 1291-3.
22. Burton GV, Bullard DE, Walther PJ, et al. Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 1988; 62: 2248-51.
23. Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1982; 1: 844-5.
24. Graus F, Vega F, Delattre J-Y, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992; 42: 536-40.
25. Cocconi G, Ceci G, Juvarra G. Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer 1985; 56: 2318-20.
26. Graus F, Abos J, Roquer J, Mazzara R, Pereira A. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes. Neurology 1990; 40: 1621-3.
27. Bird SJ. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy. Neurology 1992; 42: 1422-3.
28. Moll JW, Henzen-Logmans SC, Van der Meche FG, et al. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. Letter to the editor. J Neurol Neurosurg Psychiatry 1993; 56: 112
29. Counsell CE, McLeod M, Grant R. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 1994; 44: 1184-5.
30. Vega F, Graus F, Chen QM, Schuller E, Poisson M, Delattre JY. Intravenous (IV) immunoglobulin therapy in paraneoplastic neurologic syndromes (PNS) with antineuronal autoantibodies. Neurology 1994; 44: A157
31. Cher LM, Hochberg FH, Teruya J, Nitschke M, Valenzuela RF, Schmahmann JD, Herbert M, Rosas HD, Stowell C. Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 1995; 75: 1678-83.
32. Cook SD, Bansil S, Boos J, et al. Total lymphoid irradiation (TLI) and low-dose prednisone (LDP) in progressive multiple sclerosis (PMS). [Abstract] Neurology 1995; 45: A417
33. Fukaura H, Kent SC, Khoury SJ, et al. Induction of antigen-specific TGF-β1-secreting T cells with oral tolerization to myelin in patients with multiple sclerosis. [Abstract] Neurology 1995; 45: A436
34. Wraith DC, McDevitt HO, Steinman L, Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989; 57: 709-15.